JAOA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


JAOA • Vol 105 • No 3_suppl • March 2005 • 18-21
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manfredonia, J. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Manfredonia, J. F.

Prescribing Methadone for Pain Management in End-of-Life Care

John F. Manfredonia, DO

Dr Manfredonia is board certified in Hospice and Palliative Medicine.

Address correspondence to John F. Manfredonia, DO, FACOFP, VistaCare Regional Medical Director, 6420 E Broadway Blvd, Suite B-200, Tucson, AZ 85710.E-mail: john.manfredonia{at}vistacare.com

Methadone hydrochloride is an effective, inexpensive, and relatively safe opioid to use in the treatment of patients with chronic pain. It is especially effective in management of pain during the final stages of life, as it is the only long-acting analgesic available in liquid form. However, because methadone has a long half-life, individual wide variations, and potential for accumulation and overdosage, physicians must judiciously and conscientiously prescribe it. Also, they should closely monitor patients during the titration phase and educate them with regard to basic pharmacologic properties and potential side effects. A plan to start at low doses and proceed slowly is applicable to methadone.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Osteopathic Association.